Results 151 to 160 of about 39,918 (251)

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence

Drug Design, Development and Therapy, 2014
Ali Zalpour,1 Thein Hlaing Oo21Division of Pharmacy – Clinical Programs, 2Section of Thrombosis and Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: Anticoagulation with heparin and vitamin K ...
Zalpour A, Oo TH
doaj  

Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis [PDF]

Christiane Engelbertz, Ursula Marschall, Jannik Feld, Lena Makowski, Stefan A. Lange, Eva Freisinger, Joachim Gerß, Günter Breithardt, Andreas Faldum, Holger Reinecke, Jeanette Köppe   +10 more
openalex   +1 more source

Dissociation between the pharmacokinetics and pharmacodynamics of once‐daily rivaroxaban and twice‐daily apixaban: a randomized crossover study [PDF]

, 2017
Reinhold Kreutz, Pontus B. Persson, Dagmar Kubitza, Karin Thelen, Stefan Heitmeier, Stephan Schwers, Michael Becka, Melanie Hemmrich   +7 more
openalex   +1 more source

Cerebral infarction accompanied by cerebral bleeding in patients receiving apixaban [PDF]

, 2015
Takao Kato, Masahiro Kimura, Moriaki Inoko   +2 more
openalex   +1 more source

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats

, 2022
Ali Jaber, Israa Al‐Ani, Mohammad Hailat, Enas Daoud, Anmar Abu-Rumman, Zainab Zakaraya, Bashar J. M. Majeed, Osaid Al Meanazel, Wael Abu Dayyih   +8 more
openalex   +1 more source

Impact of NSAID Use on Bleeding Rates for Patients Taking Rivaroxaban or Apixaban. [PDF]

Rebecca Worsham, R. Darren Wood, Alan Radford   +2 more
openalex   +1 more source

MRI Findings of Intracranial Hemorrhages in ARCADIA-MRI: An Ancillary Study to the ARCADIA Trial. [PDF]

AJNR Am J Neuroradiol
Chen H, Lansberg M, Zhu G, Cassarly C, Paula Q, Kemp S, Howard G, Smith EE, Tirschwell D, Sheth KN, Kamel H, Longstreth WT, Elkind MSV, Broderick J, Lazar RM, Wintermark M.   +15 more
europepmc   +1 more source

Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis. [PDF]

Front Oncol
Malhotra V, Patel SG, Feinaj A, Amin D, Ash H, Boozo MB, Breslow Z, Trube J, Farooq MZ, Sabina M.   +9 more
europepmc   +1 more source

Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban

, 2023
Derjung M. Tarn, Kevin J. Shih, Chi‐Hong Tseng, Alveena Thomas, Janice B. Schwartz   +4 more
openalex   +1 more source

Bleeding prediction by rotational thromboelastometry in chronic hemodialysis patients with non-valvular atrial fibrillation on apixaban. [PDF]

World J Cardiol
Bacharaki D, Kyriakou E, Sardeli A, Nikolopoulos P, Triantaphyllis G, Drakou A, Makris F, Spanou E, Triantou E, Haviaras E, Fatourou A, Poulis A, Tsantes A, Kyriazis J, Lionaki S.   +14 more
europepmc   +1 more source